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The influenza virus nucleoprotein (NP) is a single-strand-RNA-binding protein associated with genome and
antigenome RNA and is one of the four virus proteins necessary for transcription and replication of viral RNA.
To better characterize the mechanism by which NP binds RNA, we undertook a physical and mutational
analysis of the polypeptide, with the strategy of identifying first the regions in direct contact with RNA, then
the classes of amino acids involved, and finally the crucial residues by mutagenesis. Chemical fragmentation
and amino acid sequencing of NP that had been UV cross linked to radiolabelled RNA showed that protein-
RNA contacts occur throughout the length of the polypeptide. Chemical modification experiments implicated
arginine but not lysine residues as important for RNA binding, while RNA-dependent changes in the intrinsic
fluorescence spectrum of NP suggested the involvement of tryptophan residues. Supporting these observations,
single-codon mutagenesis identified five tryptophan, one phenylalanine, and two arginine residues as essential
for high-affinity RNA binding at physiological temperature. In addition, mutants unable to bind RNA in vitro
were unable to support virus gene expression in vivo. The mutationally sensitive residues are not localized to
any particular region of NP but instead are distributed throughout the protein. Overall, these data are in-
consistent with previous models suggesting that the NP-RNA interaction is mediated by a discrete N-terminal
domain. Instead, we propose that high-affinity binding of RNA by NP requires the concerted interaction of
multiple regions of the protein with RNA and that the individual protein-RNA contacts are mediated by a
combination of electrostatic interactions between positively charged residues and the phosphate backbone and
planar interactions between aromatic side chains and bases.
The genome of influenza A virus is composed of eight
strands of negative-sense RNA, which in virions and infected
cells occurs in the form of ribonucleoprotein (RNP) complexes
with the virus-encoded PB1, PB2, and PA proteins and nucleo-
protein (NP). The RNP complexes represent the functional
templates for influenza virus RNA synthesis, and during infec-
tion they contain both negative-sense (vRNA) and positive-
sense (cRNA) replicative intermediate RNA but not virus
mRNA (reviewed in reference 31). The four RNP-associated
proteins are the only viral polypeptides necessary for transcrip-
tion and replication of a genome segment (24).
PB1, PB2, and PA associate to form a highly regulated
RNA-dependent RNA polymerase capable of switching be-
tween two modes of transcription to produce either capped
and polyadenylated mRNA or replicative copies of the genome
segments (31). In contrast, the major function associated
with NP is a nonenzymatic single-strand-RNA-binding activity,
which has no apparent sequence specificity (3, 27, 43, 49). This
RNA-binding activity is reflected in the stoichiometric quantity
of the protein in RNPs, from which it has been estimated that
one polypeptide interacts with around 20 nucleotides of RNA
(11). Although NP encapsidates the RNA, it does not protect
it from digestion with RNase (3, 14, 39), suggesting that the
RNA is bound on the outside of the structure. NP is apparently
responsible for the higher-order structure of RNPs, which oc-
cur in the form of helices twisted back into a double-helical
hairpin (25, 39), since the structures can persist following re-
moval of the RNA (39, 41). This implies protein-protein con-
tacts between NP monomers (41), which is consistent with the
observed cooperative nature of the NP-RNA interaction (49).
Other functions have been postulated for NP; although the
polymerase complex can efficiently transcribe short templates,
NP is required for synthesis of longer RNAs, leading to the
suggestion that it may act as a processivity factor (23). NP may
also play a role in the regulation of polymerase activity, since
cRNA and vRNA (but not mRNA) synthesis depends on a
supply of soluble (i.e., not bound to RNA) NP (4, 45). In-
triguingly, NP has recently been shown to make direct pro-
tein-protein contacts with the PB1 and PB2 subunits of the
polymerase (5, 35), but whether these contacts play a role in
regulating polymerase activity is not yet known. NP also inter-
acts with at least two cellular proteins. As expected for a pro-
tein that contains nuclear localization signals, it interacts with
polypeptides of the importin a family (36, 47), and this prox-
imal interaction is capable of directing the nuclear import of
NP-RNA complexes (37). NP also binds filamentous actin, an
interaction that influences the cellular localization of NP (13).
A molecular characterization of this multifunctional protein
is therefore of some interest, with an analysis of how the
polypeptide interacts with RNA being a logical starting point.
Two studies have identified an amino-terminal region of NP
that is capable of binding RNA (1, 29), but this fragment binds
RNA with much lower affinity than the intact polypeptide does,
suggesting that other NP sequences are important for high-
affinity binding (1). Also, little information is available at the
amino acid level on how NP interacts with RNA, and the
protein does not contain sequences with homology to previ-
ously characterized RNA-binding motifs (1, 9). However, the
protein as a whole is very basic (48), and this has led to a widely
accepted hypothesis that the positive charges of lysine and
arginine residues are involved in contacting the negatively
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charged phosphate backbone. Since our long-term aim is to
understand the mechanisms by which NP exerts its regulatory
effects on polymerase transcription, we decided to further in-
vestigate how the protein interacts with RNA. Our strategy was
to first identify which regions of the full-length polypeptide
make direct contact with RNA, to then test the importance of
various classes of amino acid for binding, and to finally employ
site-directed mutagenesis to identify the important resi-
dues. We show here that direct protein-RNA contacts occur
throughout the length of the polypeptide and not just at the
N terminus. Intrinsic fluorescence spectroscopy and chemical
modification experiments indicate the involvement of trypto-
phan and arginine residues in binding RNA, and consistent
with this, mutational analysis identified two arginine and six
aromatic residues essential for RNA binding. These mutation-
ally sensitive residues were not localized to any particular re-
gion of the polypeptide but were found throughout the protein.
Thus, high-affinity RNA binding by NP requires contributions
from multiple regions of the polypeptide.
MATERIALS AND METHODS
Plasmids, RNA, antisera, and viruses. Plasmids capable of directing the ex-
pression of authentic NP in eukaryotic cells (pKT5) or fused to maltose-binding
protein (MBP) (pMAL-NP) in Escherichia coli have been described previously
(13). Certain NP point mutants have been described previously (13), while others
were constructed by oligonucleotide-directed mutagenesis of plasmids pKT5 or
pMAL-NP by standard procedures (30). For in vitro RNA-binding assays, a
radiolabelled 178-nucleotide synthetic RNA target corresponding to influenza
virus A/PR8/34 segment 8, but with nucleotides 84 to 795 (inclusive) deleted, and
a C-to-A transversion of the penultimate base was transcribed from plasmid
pKT8-D3959 as previously described (13). Rabbit antisera raised against amino
acids 340 to 498 of A/PR8/34 NP (13) have been described previously. Recom-
binant vaccinia viruses expressing the three influenza virus A/PR8/34 P proteins
(46) or bacteriophage T7 RNA polymerase (vTF-7) (18) have been described
previously.
Expression and purification of NP. NP fused to MBP-NP was purified from
extracts of E. coli TG1 containing plasmid pMAL-NP by affinity chromatography
on amylose resin (New England Biolabs) as previously described (13). To remove
the MBP moiety, the fusion protein was digested with 0.5% (wt/wt) factor Xa
protease (New England Biolabs). After an 18-h incubation at 14°C, the protein
was loaded onto a MonoQ ion-exchange column (Pharmacia) equilibrated with
50 mM Tris-Cl (pH 7.6), and the column was eluted with a linear gradient of 0
to 2 M NaCl in 50 mM Tris-Cl (pH 7.6). MBP eluted mainly in the flowthrough
fractions, while NP eluted as a broad peak at around 800 mM NaCl.
RNA filter-binding and UV cross-linking assays. Filter-binding assays were
performed by incubating protein samples with 20 fmol of RNA (around 5,000
cpm) in 25 mM Tris-Cl (pH 7.6)–50 mM NaCl–5 mM MgCl2–0.5 mM dithio-
threitol DTT–5% glycerol at room temperature (unless otherwise specified) for
20 min. The reaction mixtures were passed through nitrocellulose filters equili-
brated in 20 mM Tris-Cl (pH 7.6)–50 mM NaCl and washed three times with 200
ml of the same buffer. Bound radioactivity was quantified by liquid scintillation
counting. For UV cross-linking experiments, reaction mixtures (generally con-
taining 125 nM MBP-NP) were incubated for 20 min as above and then irradi-
ated at 254 nm for 5 min at an intensity of 4 mW/cm2 in a Spectronics XL-1500
UV cross-linker. Free RNA was removed by digestion with 2 mg of RNase A per
ml for 30 min at room temperature before being subjected to analysis by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and autora-
diography.
Chemical modification of NP. All modification procedures included control
protein samples that were treated in parallel as described below, except that the
reactive chemical was omitted. Spectrophotometric measurements were taken
with reactions carried out in the absence of protein as a baseline.
To modify arginine side chains with p-hydroxyphenylglyoxal (p-HPG [Sigma]),
aliquots of MBP-NP in 0.1 M sodium phosphate (pH 9.0) were treated with 10
mM p-HPG (approximately a 1,000-fold molar excess) for 90 min at room
temperature in the dark. Unreacted p-HPG was removed by gel filtration over
Sephadex G-25 columns equilibrated in 0.1 M sodium phosphate (pH 9.0).
Incorporation of p-HPG was measured by spectrophotometry at 340 nm, with a
molar absorption coefficient of 1.83 3 104 M21 cm21 (50). To determine the
percentage of arginine side chains modified, aliquots of the modified MBP-NP
were separated by SDS-PAGE and stained with Coomassie brilliant blue, and the
protein concentration was determined by densitometry relative to an MBP-NP
dilution series of known concentration run in parallel.
Two procedures were used for the modification of primary amines with trini-
trobenzenesulfonic acid (TNBS). When only partial modification of lysine resi-
dues was desired, aliquots of MBP-NP were mixed with an equal volume of 0.1
M Na2B4O7 in 0.1 M NaOH and TNBS (Fisons) was added to a final concen-
tration of 22 mM. After a 5-min incubation at room temperature, half of each
sample was passed over a Sephadex G-25 column equilibrated in 10 mM HEPES
(pH 7.6)–50 mM NaCl–0.1 mM EDTA–10% glycerol to stop further reaction
and remove unreacted TNBS. The remainder of the samples were treated by the
addition of 2 volumes of 0.1 M NaH2PO4–1.5 mM Na2SO3, and the incorpora-
tion of trinitrobenzene was determined by spectrophotometry at 420 nm with a
molar absorption coefficient of 1.92 3 104 M21 cm21 (17) (potential absorption
resulting from modification of the polypeptide N terminus was disregarded).
When complete derivatization of primary amines was desired, the protein sample
(0.1 to 1 mg/ml) was diluted to 250 ml with water and an equal volume of 4%
NaHCO3 followed by 250 ml of 0.1% TNBS was added. After a 2-h incubation at
40°C, the reaction was stopped by the addition of 250 ml of 10% SDS and 125 ml
of 1 M HCl. The absorption was read at 335 nm, and the number of modified
amine groups was determined with respect to a standard curve constructed from
a dilution series of bovine serum albumin (22).
To modify primary amine groups with acetic anhydride, aliquots of MBP-NP
were mixed with an equal volume of saturated sodium acetate and treated with
two aliquots of acetic anhydride for 30 min each on ice. The samples were passed
over a Sephadex G-25 column equilibrated in storage buffer to exchange buffers
and remove unreacted anhydride, and aliquots were reacted with TNBS as
described above to quantify remaining unreacted amine groups.
Fluorescence spectroscopy. Intrinsic fluorescence measurements were re-
corded at 25°C in a Perkin-Elmer LS 50 B luminescence spectrometer with a
thermostatically controlled cuvette holder. Wavelength scans were taken from
protein samples diluted to 1 mg/ml in 50 mM NaCl–20 mM Tris-Cl (pH 7.6) with
an excitation wavelength of 280 nm (2.5-nm slit width) and an emission slit width
of 5 nm. Scans were averaged from at least five repetitions. Quenching experi-
ments were performed with 5 mg of protein per ml, allowing a 5-min equilibration
time after the addition of RNA aliquots. Fluorescence output was then inte-
grated over 1 min, before the addition of further RNA.
Polymerase-binding assays. Xenopus laevis oocytes were maintained and mi-
croinjected with synthetic mRNAs encoding the influenza virus P proteins (tran-
scribed from plasmids pKT1 to pKT3) as previously described (6, 12). For
precipitation reactions, 2.5 ml of oocyte lysate (corresponding to one-quarter of
an oocyte) was incubated with 0.5 mg of fusion protein in 100 ml of IP buffer (100
mM KCl, 50 mM Tris-Cl [pH 7.6], 5 mM MgCl2, 1 mM dithiothreitol, 0.1%
Nonidet P-40) for 1 h at room temperature. A 50-ml volume of a 50% (vol/vol)
slurry of amylose resin (New England Biolabs) in phosphate-buffered saline was
added, and incubation was continued for a further 30 min with gentle mixing.
The solid phase was collected by centrifugation and washed three times with 750
ml of IP buffer. Bound material was eluted by boiling in 40 ml of SDS-PAGE
sample buffer and analyzed by SDS-PAGE and autoradiography.
Influenza virus gene expression assay. For in vivo RNA transcription assays,
a synthetic influenza virus genome segment (flu-CAT) containing an antisense
chloramphenicol acetyltransferase (CAT) gene was produced by in vitro tran-
scription of plasmid pPB2CAT9 (a generous gift of Mark Krystal). BHK cells (in
35-mm-diameter dishes) were infected for 2 h at 37°C with recombinant vaccinia
viruses expressing the three subunits of the influenza virus polymerase (PB1-
VAC, PB2-VAC, and PA-VAC) (46) and the bacteriophage T7 RNA polymer-
ase (VTF-7) (18) at a multiplicity of infection of 5 of each virus per cell. The cells
were washed three times with serum-free medium before being subjected to
transfection with up to 1 mg of plasmid pKT5 encoding NP (or mutant deriva-
tives), 0.5 mg of pPB2CAT9 in vitro-transcribed RNA, and 10 mg of a cationic
liposome mixture (Escort; Sigma-Aldrich) as specified by the manufacturer. The
cells were incubated at 37°C for 20 h, washed three times with ice-cold phos-
phate-buffered saline, and solubilized in 1 ml of CAT enzyme-linked immunosor-
bent assay lysis buffer (Boehringer Mannheim). The lysate was clarified by
centrifugation at 14,000 3 g for 10 min at 4°C, and CAT expression was quan-
tified relative to known standards by a commercial enzyme-linked immunosor-
bent assay (Boehringer Mannheim).
RESULTS
Identification of NP sequences in direct contact with RNA.
Previously, we have shown that while MBP alone does not
detectably bind RNA, a fusion of E. coli MBP and influenza
virus NP (MBP-NP) binds RNA with similar affinity to authen-
tic NP purified from influenza virus virions (Kd ’ 20 nM) (3,
13). To further examine the interaction of NP with RNA, we
digested the fusion protein with factor Xa protease to separate
the MBP and NP domains and purified the NP to near homo-
geneity by ion-exchange chromatography (Fig. 1b, lane 1). Pu-
rified NP and MBP-NP were then tested for their RNA-bind-
ing activity by using a UV cross-linking assay. Protein samples
were incubated with a radiolabelled RNA and subjected to UV
irradiation to form cross-links between molecules in direct
contact. Following removal of free RNA by digestion with
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RNase, polypeptides were separated by SDS-PAGE, visualized
by staining with Coomassie blue dye, and examined for bound
RNA by autoradiography (Fig. 1a). Both MBP-NP and NP
became radiolabelled when subjected to this procedure (lanes
8 and 10, respectively) but did not acquire radiolabel when
incubated with RNA in the absence of UV irradiation (lanes 6
and 7). In addition, binding could be competed with unlabelled
RNA from viral and cellular sources (data not shown), indi-
cating that the reaction was specific and that the recombinant
NP showed similar sequence-independent binding properties
to those of authentic NP (3, 19, 49). Moreover, when MBP-NP
was irradiated in the presence of RNA and subsequently incu-
bated with factor Xa protease to separate the MBP and NP
moieties, only NP was radiolabelled (Fig. 1a, lane 9). There-
fore, the RNA-binding activity of MBP-NP depends solely on
the NP portion of the fusion protein, and UV cross-linking pro-
vides a convenient and specific means of examining this activity.
Previous work has shown that the N-terminal one-third of
NP binds RNA, but with substantially lower affinity than the
intact protein does (1, 29). Thus, sequences outside of the N
terminus contribute to RNA binding, either directly by con-
tacting RNA or indirectly by affecting the folding of the N
terminus (1). To distinguish between these possibilities, we
chemically digested NP which had been UV cross-linked to a
radiolabelled RNA and examined the distribution of radiolabel
among the protein fragments. After treatment with 70% for-
mic acid, which induces partial hydrolysis of aspartyl-prolyl
bonds (32), five major novel polypeptides were observed (Fig.
1b, compare lanes 1 and 2). The separated fragments were
further analyzed by transfer to a polyvinylidenefluoride mem-
brane and immunoblotting with region-specific anti-NP sera or
N-terminal amino acid sequencing. The N-terminal sequences
of fragments i to iii indicated that cleavage had occurred be-
tween the aspartyl-prolyl pairs at positions 88 and 89, 160 and
161, and 302 and 303, respectively, while fragment iv contained
the authentic N terminus (Fig. 1b). Together with the apparent
molecular weights of the polypeptides and their reactivities
with antisera directed against the C terminus of NP (Fig. 1b,
lane 5), fragments i to iv could be unambiguously assigned to
a cleavage map of NP (Fig. 1c). We could not obtain the
N-terminal sequence of polypeptide v, but since it did not react
with antiserum directed against the C terminus (Fig. 1b, lane 5)
or against amino acids 161 to 498 of NP (data not shown), it
most probably consists of the smallest predicted N-terminal
fragment (Fig. 1c). All five cleaved fragments were radiola-
belled (Fig. 1b, lane 4), indicating that residues within the
fragments were bound to RNA at the time of UV irradiation.
The radiolabelling of fragments iv and v from the N terminus
of the protein is consistent with the ability of this region to bind
RNA in isolation (1, 29) and confirms the function in the
context of the authentic protein. However, the presence of
radiolabel in fragments ii and iii indicates that the C terminus
of NP also makes direct contact with RNA. Moreover, the
similar amounts of radiolabel incorporated into the N-terminal
fragment iv and the C-terminal fragment iii (Fig. 1b, lanes 2
and 4) suggest that they participate equally in binding RNA.
Fluorescence spectroscopy of NP. Next, we wished to exam-
ine the involvement of specific classes of amino acids in NP for
RNA binding. There is much evidence from experiments with
other nucleic acid-binding proteins that aromatic amino acids
FIG. 1. RNA-binding activity of recombinant NP. (a) UV cross-linking analysis of RNA binding by MBP-NP and NP. Protein samples were incubated with
radiolabelled RNA and subjected to UV irradiation. Excess RNA was removed by RNase digestion, and samples were separated by SDS-PAGE. Radiolabelled proteins
were detected by autoradiography (32P; lanes 6 to 10), and total protein was detected by staining with Coomassie brilliant blue (Coomassie; lanes 1 to 5). Lanes: 1 and 6,
NP; 2 and 7, MBP-NP (samples in lanes 1 and 2 were not irradiated); 3 and 8, MBP-NP; 4 and 9, MBP-NP incubated with factor Xa protease after cross-linking; 5 and
10, NP. Open arrowheads mark the indicated polypeptides. Solid arrowheads mark a contaminant protein in the RNase preparation (top) or factor Xa (bottom). Also
shown are the molecular masses (in kilodaltons) of marker proteins. (b) Chemical fragmentation of NP. NP was cross-linked to a radiolabelled RNA and analyzed by SDS-
PAGE before (2) or after (1) incubation in 70% formic acid. Total and radiolabelled proteins were detected as in panel a or by Western transfer to a polyvinylidene
difluoride membrane and immunoblotting with an antiserum directed against the C terminus of NP (a-C) or by amino acid sequencing. Major NP fragments are labelled
i to v, and the N-terminal residue (NH2 residue) is given. (c) Formic acid cleavage map of NP. Numbered arrows indicate the positions of aspartyl-prolyl dipeptides
in NP, and the bracket gives the sequences against which anti-NP sera were raised. Thin lines represent the identities of the numbered NP fragments.
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can interact with single-stranded nucleic acids either by polar
interactions or by planar stacking with exposed bases (2, 7, 8,
20, 26, 38, 40, 44). To test whether this was the case for NP, we
used fluorescence spectroscopy. Tryptophan and to a lesser
extent tyrosine residues absorb light at wavelengths around 280
to 300 nm and subsequently emit some of the absorbed energy
at an intensity and wavelength dependent on the environment
of the fluorescing side chain (42).
Initial experiments revealed that emission spectra obtained
from NP by using excitiation wavelengths of 280 and 296 nm
were superimposable after scaling, suggesting that the majority
of the fluorescence arose from tryptophan residues and that
there was no significant output from tyrosine residues (data
not shown). The peak fluorescence emission (lmax) from a 10
nM NP solution was at 334 nm (Fig. 2a), indicating that on
balance, the fluorescent tryptophan residues were partially ex-
posed to solvent. In confirmation of this, under conditions
where the protein would be expected to be fully denatured (8
M guanidinium chloride), lmax was shifted to 350 nm, along
with an 80% decrease in fluorescence intensity (Fig. 2a, data
scaled to 100% for comparison). We also measured the emis-
sion spectrum of NP extracted from virions and found that it
was almost identical to that of the recombinant NP (Fig. 2a),
suggesting that the two proteins were of similar overall con-
formation. Next, we investigated whether the intrinsic fluores-
cence of NP was altered when the protein was bound to RNA.
Although lmax was not significantly altered in the presence of
saturating amounts of RNA, the fluorescence intensity was
FIG. 2. Spectroscopic analysis of the interaction of NP with RNA. (a) Fluorescence spectra of native and denatured NP. Spectra of recombinant (thick line) and
virion (thin line) NP were recorded in the absence and presence (recombinant NP only [dashed line]) of 8 M guanidinium chloride. All spectra have been scaled to
the same maximum intensity. (b) Effect of RNA on the intrinsic tryptophan fluorescence of NP. Solutions of NP in the presence (thin line) and absence (thick line)
of saturating amounts of RNA were excited at 296 nm, and fluorescent emission was measured at the plotted wavelengths. (c) Titration of fluorescence quenching by
RNA. Aliquots of RNA (plotted in terms of nucleotides of RNA added per protein molecule) were added to a solution of MBP-NP, and fluorescence emission was
measured at 335 nm after excitation at 280 nm. (d). Salt-dependent reversal of fluorescence quenching. Aliquots of NaCl were added to a sample of NP containing
saturating amounts of RNA, and fluorescence emission was measured as in panel c.
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reduced by around 35% (Fig. 2b), indicating that the fluores-
cence of one or more of the tryptophan residues was quenched
when the protein was bound to RNA. To investigate this phe-
nomenon further, we titrated a solution of NP with increasing
amounts of RNA and measured the fluorescence output (Fig.
2c). Addition of RNA caused an initially sharp but then grad-
ually decreasing fluorescence, which tended toward a plateau
when the fluorescence intensity had reached about two-thirds
of its initial value, consistent with the drop in fluorescent out-
put seen in Fig. 2b. If the fluorescence quenching was a direct
consequence of RNA binding, it would be expected to be
reversed under conditions which disrupted protein-RNA con-
tacts. We therefore performed a salt back titration and found
that addition of NaCl resulted in an increase in fluorescence
intensity, with 50% of the original signal being restored by 500
mM NaCl (Fig. 2d). This value is similar to the salt concen-
tration shown to inhibit RNA binding by 50% (49), indicating
that fluorescence quenching directly reflects the NP-RNA in-
teraction. Thus, the environment of tryptophan residues in NP
is reversibly altered by binding to RNA.
Chemical modification of NP. NP as a whole is extremely
basic (containing 21 lysine and 49 arginine residues [48]), con-
sistent with the hypothesis that positive charges on the protein
interact with the negatively charged phosphate backbone of
RNA (19). To test this, we chemically modified the protein
with reagents specific for arginine or lysine residues. We chose
treatments that could be used under relatively mild buffer
conditions, since this approach would be more likely to pre-
serve the polypeptide structure (avoiding nonspecific loss of
RNA-binding activity) and therefore would preferentially
modify surface-exposed residues. Also, to be able to moni-
tor the degree of protein modification, we chose reagents that
allowed spectrophotometric quantification of the reaction.
However, since these procedures required relatively large
quantities of protein for accurate determinations, we used
MBP-NP as a substrate since it was easier to prepare the
necessary quantities of the fusion protein and since the MBP
moiety had no apparent effect on the affinity of the polypeptide
for RNA (13).
To investigate the effect of modification of arginine residues
on RNA binding, we treated MBP-NP with p-HPG, which
reacts with the guanidyl group of arginine (50). Aliquots of
MBP-NP were incubated with a 1,000-fold molar excess of
p-HPG, and the amount incorporated into protein was deter-
mined by spectrophotometry at 340 nm (data not shown).
SDS-PAGE analysis revealed that although treatment with
p-HPG had not resulted in appreciable degradation of the
protein relative to the mock-treated sample, it had slightly
altered its electrophoretic mobility (Fig. 3a). Protein recovery
was quantified, and in conjunction with the spectrophotometric
incorporation data, it was determined that 11% of the arginine
residues had been modified (data not shown). MBP-NP con-
tains 55 arginines (49 of which are in NP [15, 21, 48]), so on
average, 6 residues per protein had been modified. The
MBP-NP samples were tested for their RNA-binding ability in
a filter assay, where it was found that the modified protein had
lost almost all activity relative to the mock-treated sample (Fig.
3b). In replicate experiments, treatment with p-HPG led to
modification of between 11 and 17% (average, 15 6 3%) of the
arginine residues (corresponding to an average of 8 amino
acids/protein), and in all cases the modified polypeptides
showed very little RNA-binding activity (data not shown).
However, the intrinsic fluorescence spectra of the treated
polypeptides were not significantly different from those of the
mock-treated samples, indicating that the modifications had
not affected the overall structure of the polypeptides (data not
shown). Therefore, a small number of arginine residues in NP
are accessible to modification by p-HPG and are crucial for
RNA binding.
To investigate the effect of modification of lysine residues on
RNA binding, we treated MBP-NP with TNBS, which intro-
duces trinitrobenzene onto e -amino groups (17, 22). The reac-
tion is influenced by pH, and so we treated MBP-NP at a range
of pH values to generate polypeptides that were modified to
various extents. MBP-NP at pH 9.6, 8.8, or 8.0 was incubated
with or without TNBS for 5 min. Unreacted TNBS was re-
moved by gel filtration, and the amount incorporated was de-
termined by spectrophotometry. Aliquots were also analyzed
by SDS-PAGE and staining with Coomassie blue dye to check
for protein recovery and integrity. The extent of e -amino group
modification ranged from 32% (pH 9.6) to 13% (pH 8.0), while
there was no apparent degradation of the polypeptides (Fig.
3c). The modified proteins were then tested for their ability to
bind RNA as before. MBP-NP samples treated at pH 8.0 or 8.8
were not substantially altered in their ability to retain the radio-
labelled RNA compared to a sample mock treated at pH 9.6
(Fig. 3d) or samples mock treated at pH 8.8 or 8.0 (data not
shown). However, MBP-NP treated at pH 9.6 showed a re-
duced (but not abolished) ability to bind RNA, retaining only
40% of the RNA at a dose where unmodified MBP-NP retained
over 80% (Fig. 3d). Therefore, modification of the lysine res-
idues of MBP-NP with TNBS did alter the ability of the protein
to bind RNA, but only at relatively high values of derivatization.
TNBS modification of lysine replaces the normal positive
charge of the amino acid side chain with a bulky and highly
negatively charged trinitrobenzene group, which could affect
RNA binding by steric effects or charge repulsion even if the
modified lysines were not directly involved in contact with
RNA. We therefore tested the effect of a smaller, uncharged
substitution of amino groups on RNA-binding activity. Accord-
ingly, portions of MBP-NP were treated with acetic anhydride
to acetylate e -amino groups. To quantify the extent of modifi-
cation, aliquots of each reaction mixture were subsequently
treated with TNBS under conditions which would be expected
to derivatize all remaining unmodified amino groups (22), to
permit spectrophotometric measurement of the number of re-
maining lysines. Protein samples were also analyzed by SDS-
PAGE and staining with Coomassie blue dye to monitor pro-
tein integrity and recovery. In the experiment in Fig. 3e,
treatment of MBP-NP with approximately 60- and 250-fold
molar excesses of acetic anhydride led to acetylation of 50 and
66% of the lysine residues, respectively, and while there was no
obvious degradation of the polypeptides, their electrophoretic
mobility had decreased slightly compared to that of mock-
treated MBP-NP. When the modified polypeptides were tested
for their ability to bind RNA, they displayed much reduced but
not completely abolished activity compared to mock-treated
MBP-NP (Fig. 3f). While 1 pmol of the unmodified sample was
sufficient to retain 30% of the input RNA and 10 pmol was
sufficient to retain over 90%, the modified polypeptides bound
less than 30% of the probe even at a dose of 30 pmol.
Thus, modification of lysines in MBP-NP with either TNBS
or acetic anhydride led to a reduction in the RNA-binding
ability of the polypeptide, but even the highest levels of deri-
vatization tested (66%; Fig. 3f) did not completely abolish
RNA binding. However, MBP contains significant numbers of
lysines (36, compared to 21 in NP [15, 21, 48]), unlike arginine
residues. Therefore, it was possible that most of the derivatisa-
tion in the experiments in Fig. 3 occurred in the MBP moiety
and that the actual modification levels of NP were significantly
lower than is predicted by simple proportion. However, when
isolated NP was treated with acetic anhydride, similar levels of
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derivatization were obtained, which again resulted in no more
than a threefold reduction in RNA-binding activity (data not
shown). Overall, the data suggest that lysines do not play
as crucial a role as arginines, where modification of a much
smaller proportion of the amino acid side chains was sufficient
to render the polypeptide almost completely unable to bind
RNA (Fig. 3b).
RNA-binding activity of mutant NP polypeptides. The ex-
periments described above implicated tryptophan and arginine
side chains as being important in RNA binding. However, they
did not address the question of which particular residues are
involved. Since NP contains only 6 tryptophans (48) (Table 1),
we mutated each codon in an attempt to define the residue(s)
involved in RNA binding. A similar approach did not seem
feasible for arginine residues, since the protein contains 49.
However, by examining sequence alignments of NPs from in-
fluenza A, B, C, and Dhori orthomyxoviruses (data not shown),
we were able to identify several conserved arginine residues at
positions 8, 150, 156, 175, 199, 204, 208, 213, 267, 391, and 416
(Table 1). These and the tryptophan residues encoded by
pMAL-NP were altered to alanine. In addition, to further
probe the importance of aromatic amino acids in binding
RNA, we mutated conserved tyrosine and phenylalanine resi-
dues at positions 148 and 412, respectively (Table 1).
FIG. 3. Chemical modification of basic residues in MBP-NP. (a and b) Modification of arginine side-chains with p-HPG. (a) Samples treated (T) or mock treated
(M) with p-HPG were analyzed by SDS-PAGE and staining with Coomassie blue. The arrow indicates MBP-NP. Also shown are values measured for the amount of
derivatization of the polypeptide (as a percentage and as residues modified per protein). Sizes of molecular mass markers (in kilodaltons) are also shown. (b) The ability
of the polypeptides to bind to a radiolabelled RNA was measured in a nitrocellulose filter-binding assay. (c and d) Modification of lysine side chains with TNBS. (c)
Samples were treated (or mock treated) with TNBS at the indicated pH values and analyzed as in panel a. (d) The RNA-binding activity of TNBS-treated samples was
measured as in panel b. (e and f) Modification of lysine side chains with acetic anhydride. (e) Samples were treated (or mock treated) with 60- and 250-fold molar
excesses of acetic anhydride and analyzed as in panel a. (f) The RNA-binding activity of acetylated samples was measured as in panel b.
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The desired changes were introduced into pMAL-NP by
site-directed mutagenesis, and the mutant fusion proteins were
expressed in E. coli and purified by affinity chromatography on
amylose columns as described above. However, many of the
mutants accumulated to lower levels than wild-type (WT)
MBP-NP did, so that when sample concentrations were ad-
justed to contain equal amounts of full-length fusion protein
(assessed by Coomassie blue staining [Fig. 4b]), they contained
larger amounts of contaminating polypeptides, including a
family of products of around 50 kDa. These polypeptides re-
acted with antisera raised against either MBP or the N termi-
nus of NP and therefore most probably represent proteolytic
products of the fusion protein (data not shown). Similar pre-
sumed degradation products were also observed in some prep-
arations of WT MBP-NP (e.g., Fig. 4b, lane 14). The protein
samples were tested for their ability to bind RNA in solution by
a UV cross-linking assay. As above, the wild-type MBP-NP
fusion protein became radiolabelled when irradiated in the
presence of the probe, indicating that it had bound to the
added RNA (Fig. 4a, lanes 1, 14, and 15), while no product was
seen in the absence of protein (lane 6). The majority of the
arginine-to-alanine mutants became radiolabelled to the same
intensity as did WT MBP-NP (lanes 2 to 5, 7 to 10, and 12),
suggesting that they were not significantly altered in their abil-
ity to bind RNA (Table 1). In contrast, the R267 and R416
mutants failed to become detectably radiolabelled (lanes 11
and 13, respectively), indicating that they had lost the ability to
bind RNA (Table 1). Of the aromatic mutants, the W104,
W207, and Y148-L mutants bound RNA at essentially WT
levels (lanes 16, 19, and 22, respectively). However, the
W330-A and F412 mutants possessed very little RNA-binding
activity (lanes 20 and 23, respectively), while the W120, W139,
and W386 mutants showed appreciable but reduced binding
(lanes 17, 18, and 21 respectively). The reduced binding of the
last three tryptophan mutants was reproducible and could be
observed across a range of protein concentrations (data not
shown), suggesting that the polypeptides had a reduced affinity
for RNA. Thus, consistent with the results of chemical modi-
TABLE 1. Phenotypic summary of NP point mutations
Mutanta RNA-bindingactivity (37°C)b
WT................................................................................................. 11
R83A ........................................................................................... 11
W1043A....................................................................................... 11
W1203A....................................................................................... 1
W1393A....................................................................................... 1
Y1483L........................................................................................ 11
R1503A ....................................................................................... 11
R1563A ....................................................................................... 11
R1753A ....................................................................................... 11
R1993A ....................................................................................... 11
R2043A ....................................................................................... 11
R2083A ....................................................................................... 11
R2133A ....................................................................................... 11
W2073A....................................................................................... 11
R2673A ....................................................................................... 2
W3303A....................................................................................... 2
W3863A....................................................................................... 1
R3913A ....................................................................................... 11
F4123A........................................................................................ 2
R4163A ....................................................................................... 2
a The identities of WT and mutated residues are given in the standard single-
letter code.
b RNA-binding activity was assessed by UV cross-linking. 11, essentially WT
behavior; 1, reduced ability to bind RNA; 2, little or no observable RNA-
binding activity.
FIG. 4. RNA-binding activity of NP mutants containing single-amino-acid changes. WT and mutated MBP-NP (as labelled) were expressed and purified from E.
coli. Protein samples were adjusted to contain approximately equal amounts of full-length fusion protein and assayed for their ability to bind radiolabelled RNA in a
UV cross-linking assay. Polypeptides were analyzed by SDS-PAGE and autoradiography (a) and staining with Coomassie brilliant blue (b). The autoradiograms in panel
a were taken from the stained gels in panel b. Also indicated by arrowheads are molecular size markers (in kilodaltons) and the position of MBP-NP.
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fication and fluorescence spectroscopy, two arginine, one phe-
nyalanine, and four tryptophan residues were identified as
being essential for WT RNA-binding activity. In addition,
there was no clear correlation between WT RNA-binding ac-
tivity and the quantity of copurifying MBP-NP “stub” (e.g.,
compare lanes 21 and 22). Also, the MBP-NP stub possessed
very little RNA-binding activity in this assay.
Recently, we have shown that the mutations in the NPs of
the temperature-sensitive (ts) viruses A/WSN/33 ts56 and
A/FPV/Rostock/34 tsG81 render the RNA-binding activity of
the polypeptides ts (35). We therefore tested certain of the
point mutants described here for ts RNA-binding. Mutant
MBP-NP fusion proteins were prepared as above from E. coli
cultures grown at 30°C, and their RNA-binding activities were
compared to those of the polypeptides prepared from cultures
incubated at 37°C. The abilities of W330-A and W386-A to
bind RNA were not appreciably improved by synthesis at 30°C
(data not shown). In contrast, when the R267-A, F412-A, and
R416-A polypeptides were prepared at 30°C and assayed for
their ability to bind RNA at 30°C, they showed much increased
activity compared to the same proteins synthesized at 37°C
(Fig. 5a, compare lanes 3 and 4, 5 and 6, 7 and 8), with overall
binding activity approaching that of the WT protein (lane 1).
When the mutant polypeptides synthesized at 30°C were as-
sayed for their ability to bind RNA at 37°C, F412 retained full
activity (compare lanes 5 and 11). However, the R267 and
R416 polypeptides showed reduced affinity for RNA at the
higher temperature, although it was still greater than that seen
with the same polypeptide prepared at 37°C (compare lane 9
with lanes 3 and 10, and compare lane 13 with lanes 7 and 14).
The differential binding activities could not be explained by
increased degradation of the polypeptides at 37°C, either dur-
ing expression and purification or during the cross-linking as-
say (Fig. 5b). Thus, the alteration of residue R267, F412, or
R416 induces ts RNA-binding activity in NP. The phenotype of
the F412 mutant differs slightly from those of the R267 and
R416 mutants in that F412 synthesized at 30°C is apparently
more thermostable than the last two polypeptides. To investi-
gate the latter aspect further, we titrated the thermal stability
of RNA-binding by WT and mutant NPs. In one set of exper-
iments, aliquots of MBP-NP were incubated at various tem-
peratures in the presence of a radiolabelled RNA and bound
RNA measured using a nitrocellulose filter-binding assay. Al-
ternatively, protein was heated in the absence of RNA before
addition of the radiolabelled probe. Increasing temperature
caused a gradual loss of RNA-binding activity by WT MBP-
NP, although RNP complexes were remarkably stable, retain-
ing 52% of their initial binding activity at 60°C (Fig. 5c). How-
ever, when the WT protein was heated in the absence of RNA,
binding activity was more thermolabile, decreasing the temper-
ature at which 50% binding activity was lost by almost 10°C
(Fig. 5c). In replicate experiments, WT RNP complexes were
50% dissociated at 63.5 6 0.5°C, compared to 54.5 6 1.5°C for
protein heated in isolation. Consistent with the experiment in
Fig. 5a, the R267 mutant (prepared at 30°C) was markedly
more ts than WT NP when the polypeptide was heated in the
absence of RNA, losing 50% of its RNA-binding activity at
only 38°C (Fig. 5c). However, complexes of R267 and RNA
possessed dramatically increased thermostability, requiring
heating at 55°C for 50% dissociation. Thus, the apparent ther-
mal stability of NP is increased by binding RNA, especially for
a ts mutant.
Interaction of the NP RNA-binding mutants with the influ-
enza virus polymerase. The mutational analysis described
above identified specific residues whose substitution reduced
RNA-binding activity, potentially through direct alteration of
an amino acid side chain normally in contact with RNA. Al-
ternatively, some or all of the alterations may have exerted an
indirect effect on RNA binding by perturbing the polypeptide
structure, a possibility which seemed especially plausible for
the mutations which rendered RNA binding ts. However, de-
fects which caused gross malfolding of the polypeptide struc-
FIG. 5. Effect of temperature on the NP-RNA interaction. (a and b) MBP-NP fusion proteins were prepared from E. coli cultures grown at the indicated
temperatures and assayed for their ability to bind a radiolabelled RNA as in Fig. 4. (a and b) The autoradiogram (a) and the equivalent Coomassie brilliant blue-stained
gel (b) are presented. (c) Thermal denaturation of RNA-binding activity. The indicated polypeptides (100 nM) were tested for their ability to bind a radiolabelled RNA
(1 nM) at the indicated temperatures by filtration through a nitrocellulose filter. Protein was heated in the presence (solid symbols) or absence (open symbols) of RNA.
Values are plotted as a percentage of the amount bound by each protein at 30°C.
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ture would be expected to affect other functions of NP. Previ-
ously, we have shown that the W120 and R267 mutations have
minimal effect on the ability of NP to bind filamentous actin
(13). Similarly, the W120, W139, R267, W330, W386, and F412
mutations have little effect on the ability of the polypeptides to
form NP-NP oligomers (16). Recent work has shown that NP
also makes direct protein-protein contacts with the PB1 and
PB2 subunits of the influenza virus polymerase (5, 35). We
therefore tested the ability of the RNA-binding mutants to
interact with the polymerase complex. Previously, we have
shown that the three influenza virus P proteins assemble into a
complex in X. laevis oocytes microinjected with the appropriate
mRNAs and that this system provides a convenient source of
soluble radiolabelled protein for binding studies (6, 12, 35).
Accordingly, oocyte lysates containing the polymerase complex
were incubated with MBP or with WT and mutant MBP-NP
polypeptides (synthesized at 37°C). After the addition of amy-
lose resin, the solid phase was collected, washed, and examined
for bound polypeptides. All three P proteins were precipitated
by WT MBP-NP but not by MBP alone (Fig. 6, lanes 2 and 3),
indicating a specific association between NP and the polymer-
ase complex. Furthermore, similar quantities of the polymer-
ase complex were precipitated by all the mutant MBP-NPs
defective for RNA binding (lanes 4 to 10). Therefore the point
mutations which disrupt RNA-binding activity are not associ-
ated with the general loss of other NP functions.
Ability of the NP RNA-binding mutants to support virus
gene expression. NP is known to be essential for virus RNA
synthesis (reviewed in reference 31), and an artificial system
has been established where NP and the three subunits of the
influenza virus RNA polymerase supplied from recombinant
vaccinia viruses are sufficient to drive transcription and repli-
cation of a synthetic influenza virus genome segment in cells
(24). We used an adaptation of this system where NP is sup-
plied from transfected plasmids (13) to test the effects of point
mutations disruptive of RNA binding on the ability of NP
to support virus gene expression. The mutant NP genes were
subcloned into plasmid pKT5 (13), which directs the expres-
sion of unfused NP under the control of the bacteriophage T7
RNA polymerase promoter. BHK cells were multiply infected
with vaccinia viruses expressing the influenza virus and bacte-
riophage T7 RNA polymerase subunits (18, 46) and trans-
fected with WT or mutant pKT5 plasmids and the synthetic
flu-CAT RNA, and 20 h later the cells were lysed and the
accumulation of CAT polypeptide was measured. Figure 7
shows the activities of the NP RNA-binding mutants relative to
the WT polypeptide. All four mutants which were unable to
bind RNA in vitro (Fig. 7a, R267, W330, F412, and R416)
failed to support appreciable levels of virus gene expression.
Of the three mutants which displayed reduced RNA-binding
activity (RNA 1), one also failed to produce significant levels
of CAT polypeptide (Fig. 7a, W120) whereas the other two
(W139 and W386) supported appreciable but diminished levels
of gene expression relative to the WT protein. Western blot
analysis of parallel transfections showed that the majority of
the NP mutants (with the exception of W120) accumulated in
similar quantities to WT NP (Fig. 7b), indicating that their
diminished ability to support virus RNA synthesis was not
simply the result of poor expression. Thus, the in vitro pheno-
types of the mutants correlate with their in vivo function, and
as expected, the RNA-binding activity of NP is essential for
virus gene expression.
FIG. 6. Ability of RNA-binding mutants to interact with the polymerase
complex. Radiolabelled cell lysate containing the three influenza virus P proteins
was analyzed by SDS-PAGE and autoradiography before (Total) or after binding
to the indicated polypeptides. Open arrowheads indicate molecular mass mark-
ers (in kilodaltons); solid arrows are as labelled.
FIG. 7. Ability of NP RNA-binding mutants to support virus gene expres-
sion. (a) BHK cells were infected with recombinant vaccinia viruses expressing
the three subunits of the influenza virus RNA polymerase and T7 RNA poly-
merase and transfected with 1 mg each of a synthetic influenza virus segment
containing an antisense CAT gene and plasmid encoding WT or mutant NPs, and
the resulting accumulation of CAT polypeptide was quantified. Results are
expressed as the percent activity 6 standard error (n $ 3) for the mutants
relative to WT NP. (b) Accumulation of WT and mutant NP in cells. Cells
transfected with plasmids encoding WT or mutant NP molecules (or with empty
plasmid vector, pKT0) were examined for NP accumulation by Western blot
analysis with anti-NP serum.
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DISCUSSION
Previously, two studies mapped the minimal sequences of
NP capable of binding RNA to the N-terminal one-third of the
polypeptide (Fig. 8) (1, 29). However, this truncated fragment
of NP bound to RNA with lower affinity than did the WT
protein, indicating the necessity for other sequences for full
binding activity (1). In this study, we show by UV cross-linking
and chemical fragmentation that at least two sequences within
the C-terminal two-thirds of NP directly contact RNA (Fig.
1b). Furthermore, we found that single-amino-acid replace-
ments throughout much of the length of NP were capable of
disrupting the interaction of the polypeptide with RNA (sum-
marized in Fig. 8). The widespread mutational sensitivity of
RNA-binding activity is in contrast to the sequence require-
ments for the characterized protein-protein interactions medi-
ated by NP, in which for any one ligand, disruptive point
mutations are generally more localized in distribution (Fig. 8).
The majority of the RNA-binding mutations do not affect
other functions of NP, arguing against global malfolding of the
polypeptide. None of the lesions described here decrease the
ability of NP to interact with the polymerase complex (Fig. 6).
With the exception of R416, which also decreases oligomer-
ization of the polypeptide, none of the mutations affecting
RNA binding block the ability of the polypeptides to form
NP-NP contacts (16). In addition, the W120 and R267 muta-
tions have little effect on the interactions of the proteins with
filamentous actin (13). Thus, the majority of the mutations
reduce RNA-binding activity specifically. However, some of
them do so in a temperature-dependent fashion, affecting the
function significantly at 37°C but much less so at 30°C. Thus,
for these mutants at least, it seems unlikely that the sequence
alterations have removed an amino acid side chain normally in
direct contact with RNA. Yet, as discussed above, the muta-
tions are clearly not disrupting the global folding of NP at the
elevated temperature, since the polypeptides retain the other
activities associated with NP. Furthermore, any effects of the
mutations on the overall structure of NP were too subtle to be
detected as changes in the resistance of the polypeptides to
partial digestion with trypsin or chymotrypsin proteases (data
not shown).
Overall, these data are not consistent with the hypothesis
that RNA binding by NP is mediated through a discrete N-
terminal region of the protein (1, 29). Instead, we propose that
high-affinity binding of RNA by NP requires the concerted
interaction of multiple regions of the protein with RNA. This
hypothesis is consistent with the demonstration of direct pro-
tein-RNA contacts outside of the N terminus (Fig. 1b) and the
identification of inhibitory mutations throughout the length of
NP (Fig. 4). This model is also consistent with the proposed
wrapping of RNA around NP in a nucleosome-like pattern (25,
49), as well as with the increased thermal stability of WT
protein-RNA complexes and the ability of RNA to rescue the
binding activity of a ts mutant at elevated temperatures (Fig.
5c). Within this framework, several possibilities exist to explain
the ability of widely separated point mutations to ablate RNA
binding without affecting other functions of NP. One possibility
is that high-affinity binding results from the multiplicative con-
tribution of independent binding sites, so that the loss of any
one interaction causes a relatively large decrease in binding
affinity resulting from what is effectively a loss of avidity. How-
ever, we have recently found evidence from circular dichroism
spectroscopy that NP undergoes a conformational change on
binding RNA (data not shown). Therefore, an alternative hy-
pothesis is that multiple protein-RNA contacts are required to
drive this conformational change necessary for high-affinity
binding and that the loss of any one interaction interrupts the
process.
Within the model of polyvalent binding, we propose that the
individual protein-RNA interactions are mediated by a com-
bination of electrostatic interactions between positively
charged residues and the phosphate backbone and planar
interactions between aromatic side chains and bases. This is
consistent with the sensitivity of the protein to chemical mod-
ification of arginine residues (Fig. 3), the changes in the envi-
ronment of tryptophan residues upon RNA binding (Fig. 2),
and the requirement for specific arginine and aromatic resi-
dues (Fig. 4). In addition, this mode of single-stranded-nucleic-
acid binding is well supported by mutational and structural
studies of other DNA- and RNA-binding proteins (7, 10, 20,
28, 38, 40, 44). Two studies which probed influenza virus RNP
complexes by measuring the protection afforded the RNA
from chemical and enzymatic attack found a general protec-
tion of RNA phosphates but sensitivity of the bases (3, 28).
This was interpreted as indicating that the protein binds to the
phosphate backbone and not to the Watson-Crick positions of
the bases. However, such findings do not rule out contacts
between the protein and other positions of the bases. Indeed,
NP binds preferentially to pyrimidine homopolymers, which
suggests an interaction between the protein and bases (1).
Also, considering that NP is not a sequence-specific RNA-
binding protein, RNA modification experiments may well re-
flect an average state of protection for any one position, rather
than a static interaction.
Recently, we have determined that the mutations defined as
the ts lesions in the NPs of viruses A/WSN/33 ts56 (S314-N)
(33) and A/FPV/Rostock/34 tsG81 (A332-T) (34) specifically
induce ts RNA-binding by NP (35). Since these viruses are
considered specifically defective for cRNA and vRNA tran-
scription, this finding has implications for the function of NP
during replicative transcription. The panel of NP mutants de-
scribed here should therefore prove useful tools for improving
our understanding of the functions of NP in influenza virus
transcription.
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